Category Archives: MS Treatment

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Susanne L. Meline to its Board of Directors, effective January 31, 2021 Continue reading →

Our hopes have been dashed so many times by miracle cures touted for COVID-19, so on September 25, when President Nicols Maduro of Venezuela promoted one with no scientific evidence whatsoever to back it up, nobody could blame the research community for being just a bit skeptical. Of course, we all remember hydroxychloroquine, the anti-malaria drug pushed by former U.S. Continue reading →

We need to throw the book at them, Rep. Ruben Gallego, an Arizona Democrat and former Marine infantryman, told CNN, regarding the service members and veterans involved in the Jan. 6 assault on the Capitol. Continue reading →

February 02, 2021 08:00 ET | Source: Protara Therapeutics NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors Continue reading →

February 02, 2021 08:00 ET | Source: Gain Therapeutics BETHESDA, Md., Feb. Continue reading →

A clinical trial of a gene therapy for an inherited condition leading to vision loss made an unexpected finding: Patients treated in one eye experienced improvement in the other eye as well. Researchers gave the experimental therapy to 37 people with Leber hereditary optic neuropathy, or LHON, a rare genetic disease that can lead to irreversible vision loss, according to a paper published Wednesday in Science Translational Medicine. The disease, which primarily affects young men, can cause sudden loss of central vision in one eye, usually followed by the other eye within a short period of time. Continue reading →

Disability, fatigue, depression, cognitive impairment, and unemployment are primary risk factors for a poor quality of life in people with multiple sclerosis (MS), according to a recent review study. Conversely, higher self-esteem, self-efficacy, resilience, and social support were identified as protective factors for quality of life (QoL). Review findings also showed that most psychological interventions, such as mindfulness, cognitive-behavioral therapy, self-help groups, and self-management, successfully improved QoL in these patients Continue reading →

A woman from Oxfordshire, who was diagnosed with Multiple Sclerosis, has said some doctors made her feel as though she was "making it up" when she came forward with symptoms in her early 20s. Sasha Braun, who's 25 and from South Oxfordshire, was diagnosed with relapsing remitting MS in 2018. The trainee vicar is sharing her story as new research shows as many as one in five people diagnosed with MS are under 30 Continue reading →

TORONTO--(BUSINESS WIRE)--Highland Therapeutics Inc. (Highland) today announced the appointment of Stephanie C. Continue reading →

MARINA DEL REY, Calif., Dec. 9, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. Continue reading →